Fedora Grande Selected Research

Fedora Grande Research Topics

Disease

17	Neoplasms (Cancer) 08/2022 - 02/2007
8	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2009
4	Obesity 01/2024 - 01/2019
3	Inflammation (Inflammations) 01/2023 - 01/2016
3	Infections 09/2021 - 04/2021
3	Colonic Neoplasms (Colon Cancer) 07/2013 - 03/2009
3	Ovarian Neoplasms (Ovarian Cancer) 06/2013 - 03/2009
2	Triple Negative Breast Neoplasms 05/2024 - 01/2019
2	Hypertension (High Blood Pressure) 04/2021 - 01/2016
2	Carcinogenesis 01/2020 - 01/2016
2	Pathologic Processes 10/2017 - 01/2016
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Hypercholesterolemia 09/2021
1	Sepsis (Septicemia) 05/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Chronic Pain 04/2021
1	Neuralgia (Stump Neuralgia) 04/2021
1	COVID-19 04/2021
1	Hypertrophy 01/2021
1	HIV Infections (HIV Infection) 02/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 04/2018
1	Neoplasm Metastasis (Metastasis) 10/2016
1	WHIM syndrome 01/2013

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 01/2023 - 02/2007
4	Hormones (Hormone)IBA 01/2020 - 03/2009
3	Proteins (Proteins, Gene)FDA Link 09/2021 - 04/2018
3	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 01/2015
3	LigandsIBA 10/2017 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2016
2	Antiviral Agents (Antivirals)IBA 09/2021 - 04/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 01/2016
2	QuercetinIBA 01/2019 - 11/2017
2	Estrogen ReceptorsIBA 01/2019 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 02/2012 - 03/2009
2	HydrazinesIBA 06/2009 - 05/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2009 - 03/2009
1	EstetrolIBA 05/2024
1	FlavonoidsIBA 01/2024
1	Dietary Fats (Dietary Fat)IBA 01/2024
1	AntioxidantsIBA 12/2023
1	Lipase (Acid Lipase)FDA Link 12/2023
1	Amylases FDA Link 12/2023
1	EnzymesIBA 12/2023
1	GlucosidasesIBA 12/2023
1	Letrozole (Femara)FDA LinkGeneric 12/2022
1	Aromatase (CYP19)IBA 12/2022
1	ProdrugsIBA 08/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2021
1	Peptide Hydrolases (Proteases)FDA Link 09/2021
1	Chromogranin AIBA 05/2021
1	Messenger RNA (mRNA)IBA 05/2021
1	LipopolysaccharidesIBA 05/2021
1	chromogranin A (344-358)IBA 05/2021
1	Toll-Like Receptor 4IBA 05/2021
1	p38 Mitogen-Activated Protein KinasesIBA 05/2021
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	1,4-dihydropyridine (dihydropyridine)IBA 04/2021
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 04/2021
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 04/2021
1	Surface-Active Agents (Surfactants)IBA 04/2021
1	Poloxamer (Poloxamer 407)IBA 04/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2021
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2020
1	carbazoleIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	LeptinIBA 01/2020
1	Aromatase InhibitorsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	CarbazolesIBA 01/2020
1	CytokinesIBA 01/2020
1	Estrogen Receptor alphaIBA 01/2020
1	MethylcholanthreneIBA 08/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Furylfuramide (AF2)IBA 01/2019
1	ChromatinIBA 01/2019
1	LipidsIBA 01/2019
1	PolyphenolsIBA 01/2019
1	GenisteinIBA 04/2018
1	IsoflavonesIBA 04/2018
1	CXC ChemokinesIBA 10/2017
1	RetinoidsIBA 10/2016
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 10/2016
1	Conditioned Culture MediaIBA 10/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 10/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2016
1	Co-Repressor ProteinsIBA 10/2016
1	hydroxide ionIBA 01/2016
1	Cyclin D1IBA 07/2013
1	InterleukinsIBA 06/2013
1	plerixafor FDA Link 01/2013
1	JNJ 26854165IBA 01/2011
1	ImidazolinesIBA 01/2011
1	tryptamineIBA 01/2011
1	RG7112IBA 01/2011
1	Antineoplastic Agents (Antineoplastics)IBA 06/2009

Therapy/Procedure

9	Therapeutics 08/2022 - 02/2007
1	Oral Administration 06/2013